Treace Medical Concepts, Inc. (NASDAQ: TMCI), a dynamic player in the healthcare sector, specializes in revolutionary medical devices aimed at addressing orthopedic challenges. With a market capitalization of approximately $369.25..
InnovAge Holding Corp. (NASDAQ: INNV) presents an intriguing opportunity for investors looking to tap into the healthcare sector, specifically within the niche of medical care facilities for seniors. With a..
Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with a notable potential upside of 289.14%, according to analyst ratings. This San Diego-based..
Sionna Therapeutics, Inc. (NASDAQ: SION) is drawing significant attention in the biotechnology sector, particularly for investors looking to capitalize on the burgeoning field of cystic fibrosis treatment. With a market..
Enhabit, Inc. (NASDAQ: EHAB), a prominent player in the healthcare sector specializing in home health and hospice services, has been drawing the attention of investors amid its recent stock movements..
Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, is gaining significant attention in the healthcare sector due to its innovative approach to cancer treatment. With a market cap of $475.6..
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, is gaining attention in the healthcare sector with its innovative approach to treating diseases with high unmet medical needs. With a..
Personalis, Inc. (NASDAQ: PSNL) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $513.17 million, this U.S.-based company is carving..
REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotechnology company, has piqued investor interest with its promising pipeline and remarkable potential upside. With a market capitalization of $511.64 million, the company is..
Septerna, Inc. (NASDAQ: SEPN) stands out in the biotechnology sector with an intriguing investment profile, underscored by a potential upside of 127.35% according to the average analyst target price. Headquartered..
MeiraGTx Holdings plc (NASDAQ: MGTX) offers a compelling opportunity for investors seeking exposure to the burgeoning field of genetic medicine. Specializing in the development of transformative treatments for serious diseases,..
COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering biotechnology firm focused on mental health, is making waves in the healthcare sector. With a market capitalization of $422.9 million, this UK-based company..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a dynamic player in the biotechnology sector, is capturing significant attention from investors, particularly with its potential upside of over 102%. Operating at the cutting..
Bicycle Therapeutics plc (NASDAQ: BCYC), a UK-based biotechnology firm, is capturing investor attention with a compelling potential upside of 202.33%. This clinical-stage pharmaceutical company is pioneering a new class of..
Verve Therapeutics, Inc. (NASDAQ: VERV) is capturing the attention of investors with its bold forays into the landscape of gene editing, targeting cardiovascular diseases. As a clinical-stage biotechnology company based..
SIGA Technologies Inc. (SIGA), a commercial-stage pharmaceutical company, is carving a niche within the healthcare sector, specifically targeting the health security market. Headquartered in New York, SIGA focuses on developing..
Arbutus Biopharma Corporation (NASDAQ: ABUS) stands as a noteworthy entity in the biotechnology industry, particularly for investors with a keen eye on the healthcare sector. With a current market capitalization..
AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company based in San Diego, is capturing investor attention with its impressive growth potential in the healthcare sector. Specializing in delivering immunology therapeutics,..
Semler Scientific, Inc. (NASDAQ: SMLR), a pivotal player in the healthcare sector, operates within the medical devices industry, providing innovative technology solutions designed to enhance clinical effectiveness. Headquartered in Santa..
Arvinas, Inc. (NASDAQ: ARVN) is making waves in the biotechnology sector with its innovative approach to drug development, primarily focusing on the degradation of disease-causing proteins through its proprietary PROTAC..
